Global Cause
In this issue
-
Building a better world — the One Health way
The health of people is inextricably linked to the health of animals, plants and our shared environment, therefore it’s imperative for professionals in different sectors to work closely together. Our world is more connected than ever. While this has obvious social, cultural and economic benefits, it also has a more sinister implication: it makes it...
-
The growing threat of pandemics
Whilst COVID-19 caught the world off guard, the speed at which it spread and the extent of its impact on people’s lives came as a great shock to most. However, some were not surprised at all. COVID-19 is the third recent jump of an animal coronavirus into humans, after SARS and MERS, plus other coronaviruses...
-
Our campaign partners
The ESCV 2022 Annual Conference will take place in Manchester from 7-10 September 2022 and will offer the latest research and innovations in the field of clinical virology. Portugal will host the EAAP 2022 between 5th – 9th September 2022. Don’t be left out, just over a month to go before the biggest European animal...
-
On the way to a pre-antibiotic-age
AMR is a key cross-border health issue for Europe and the world. This silent pandemic is already affecting our health today and will continue in the future. Without effective action, AMR will take us back to a pre-antibiotic age when death by infection was much more common. Each year, already more than 700,000 people die...
-
Diagnostic tests are vital in the fight against antimicrobial resistance
The coronavirus pandemic has focussed the world’s attention on the role and importance of diagnostic testing. Diagnostic tests provide essential data to support treatment decisions; 70% of patient information comes from diagnostic tests. Many tests are done in hospital laboratories, but increasingly, technological improvements are enabling access to tests outside traditional settings. Keeping the focus...
-
How to address the challenges of collecting quality health data under COVID-19 disruptions
The COVID-19 pandemic is impacting the fight against HIV, tuberculosis and malaria. Health and community systems are overwhelmed, treatment and prevention programs are disrupted, and resources are diverted. Frequent, high-quality and timely data allows countries to quickly identify and respond to changes in epidemiology and to learn which interventions are having most impact. To track the progress...
-
Rapid antimicrobial resistance detection for early directed therapies against infectious diseases
In recent years, antimicrobial resistance (AMR) has reached proportions of such significance to propel national and global health authorities to regard AMR as today’s “serious threat” worldwide. Targeting AMR has important clinical implications not only related to diagnosis and management1 but also prevention of infectious diseases2, particularly those causing sepsis3. Determinants of deaths associated with...
-
Working together towards equal, available, and affordable access
The pharmaceutical industry is collaborating on an unprecedented scale and stepping up to develop COVID-19 treatments and vaccines. Thomas Cueni, Director General of the IFPMA, explains how. “I think industry has really stepped up. They are an integral part of the Access to COVID-19 Tools (ACT) Accelerator, they are very engaged in the vaccine development,”...
-
s Sponsored
How collaboration could be key to beating the pandemic
The fight against COVID-19 has involved organisations across the world, uniting to share knowledge, resources and innovation. A “rapid response call” was put out by EIT Health in April for projects that would start immediately and have an immediate impact on the COVID-19 pandemic. But these projects need financial support. Over €6 million has been...
-
Uganda gets innovative in its drive against HIV
Uganda has developed an efficient way to get blood samples from out-of-the-way communities to various lab locations for HIV testing, speeding up diagnosis and improving treatment.